<?xml version="1.0" encoding="UTF-8"?>
<p class="p">In vitro and in vivo, α-syn can undergo amyloid fibril formation, with a typical cross-β sheet structure by a nucleation-dependent mechanism [
 <xref rid="B97-molecules-23-01531" ref-type="bibr" class="xref">97</xref>,
 <xref rid="B111-molecules-23-01531" ref-type="bibr" class="xref">111</xref>]. The nucleation process is the rate-limiting step in fibril formation that gives rise to the production of soluble oligomers, proto-fibrils and finally mature amyloid fibrils (
 <xref ref-type="fig" rid="molecules-23-01531-f002" class="xref">Figure 2</xref>c). Recently, several lines of evidence indicate that the soluble oligomers, rather than the mature fibrils, may be the toxic species associated with PD [
 <xref rid="B112-molecules-23-01531" ref-type="bibr" class="xref">112</xref>], and LB/LN are a protective and inert forms in which fibrils converge [
 <xref rid="B113-molecules-23-01531" ref-type="bibr" class="xref">113</xref>].
</p>
